GSA Capital Partners’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-33,529
| Closed | -$53K | – | 2132 |
|
|
2024
Q1 | $53K | Sell |
33,529
-300,944
| -90% | -$476K | ﹤0.01% | 1532 |
|
|
2023
Q4 | $287K | Buy |
334,473
+120,797
| +57% | +$104K | 0.02% | 1136 |
|
|
2023
Q3 | $229K | Sell |
213,676
-107,236
| -33% | -$115K | 0.02% | 1227 |
|
|
2023
Q2 | $831K | Sell |
320,912
-108,557
| -25% | -$281K | 0.08% | 418 |
|
|
2023
Q1 | $1.75M | Buy |
429,469
+300,190
| +232% | +$1.22M | 0.17% | 105 |
|
|
2022
Q4 | $649K | Buy |
129,279
+118,220
| +1,069% | +$593K | 0.08% | 438 |
|
|
2022
Q3 | $145K | Buy |
+11,059
| New | +$145K | 0.02% | 1304 |
|
|
2021
Q1 | – | Sell |
-46,908
| Closed | -$1.42M | – | 1586 |
|
|
2020
Q4 | $1.42M | Buy |
+46,908
| New | +$1.42M | 0.23% | 63 |
|